1. Home
  2. OVLY vs PBYI Comparison

OVLY vs PBYI Comparison

Compare OVLY & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

HOLD

Current Price

$33.13

Market Cap

269.7M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$6.62

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
PBYI
Founded
1990
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
263.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OVLY
PBYI
Price
$33.13
$6.62
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
15.7K
441.5K
Earning Date
01-23-2026
02-26-2026
Dividend Yield
2.26%
N/A
EPS Growth
N/A
59.87
EPS
2.88
0.74
Revenue
$80,924,000.00
$211,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.52
$8.88
Revenue Growth
3.47
N/A
52 Week Low
$22.70
$2.58
52 Week High
$34.00
$7.29

Technical Indicators

Market Signals
Indicator
OVLY
PBYI
Relative Strength Index (RSI) 66.29 53.21
Support Level $31.66 $6.75
Resistance Level $34.00 $6.98
Average True Range (ATR) 0.55 0.32
MACD 0.04 -0.03
Stochastic Oscillator 69.81 35.61

Price Performance

Historical Comparison
OVLY
PBYI

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: